Adnams Is Fixing Its Balance Sheet, but the 6,600% Share Run Is a Float Story, Not a Recovery

Adnams — the 140-year-old brewer, distiller and pub operator based in Southwold, Suffolk — just reported first-half revenue of £27.4 million, down from £30.1 million a year earlier. That is the sort of headline that normally sinks a small-capper. Instead, the stock is up again: Class B shares jumped 43% in a single day this week to an indicated 1,900p, a move built on roughly 300 shares trading, and the shares are up more than 6,000% over the past year. The market keeps celebrating a comeback that the latest cash-flow evidence has not yet delivered.

That gap — a massive rerating against a business still reporting losses — is what any investor should understand before being tempted to chase it.

The balance sheet really is improving

Credit where it is due. Adnams nearly sank; now it is demonstrably repairing its finances. Over 2025 the company cut net bank debt from £15.3 million to £9.2 million, swung from a £1.2 million operating loss to a small operating profit, and trimmed its pre-tax loss from £2.8 million to £0.7 million. Its borrowing facilities with Barclays were extended through June 2027, and at the annual meeting management said the interest bill for 2026 would be about £0.5 million lower than 2025. On my framework, the survival test — leverage coming down, covenants intact, lenders patient — is passing.

The first half of 2026 confirms the direction. Interest payable fell by half to £0.4 million as debt kept coming down, and operating expenses fell by more than £2 million through efficiency and overhead control.

…but the operating numbers are still in the red

Here is the tension the price is ignoring. Half-year revenue fell to £27.4 million, and while a chunk of that is the deliberate sale of tenanted pubs in 2025 — a downsizing, not necessarily a deterioration — the underlying result swung the wrong way. The company reported an operating loss of £1.0 million against a £0.7 million profit in the first half of 2025; even before exceptional items it was a £0.8 million loss versus a £0.5 million profit. The pre-tax loss of £1.4 million was broadly flat year on year, and the after-tax loss only improved to £1.1 million because interest fell and disposals booked £1.2 million of gains.

Cash is the more telling number. At the end of June, cash at bank stood at minus £2.36 million, versus a positive £298,000 in December. The directors keep the going-concern basis only because they project staying inside banking covenants; there is still no interim dividend. In other words, the repair is real but slow — a business cutting its way toward profitability, not yet generating cash from operations.

The run is a float story, not a re-rating

So what explains a stock that has risen more than 6,000% in a year against a company still reporting losses? The answer sits in the mechanics of the market for these shares, not in the economics of the brewer. There are only roughly 285,800 tradable Class B shares, putting the whole company's market value near £5 million — a few times the value of a good pub, for a business reporting £27 million of half-year sales and £17.9 million of net assets. Trading is so thin that the entire 43% jump this week was established by about 300 shares. Quoted spreads are enormous — one recent guide showed bids near 1,200p against offers near 2,000p around a 1,600p mid — so the last traded price is close to meaningless, and whatever you see quoted is not necessarily a price at which you can sell any real position.

This is the mirror image of the early Adnams story. When the shares were genuinely distressed and the balance sheet was the whole question, the cheapness carried a margin of safety — this was exactly the kind of name worth a hard look. The stock ran up because a tiny float plus a believable turnaround narrative lets a few hundred shares mark the price wherever the momentum takes it. The problem for anyone arriving now is that the cheapness that made the position interesting has been consumed by that run, while the cash flows still do not support the level. You would be paying a rerating that has already happened, for a recovery that the H1 data shows is still in progress, in a stock whose own price has stopped being a reliable measure of its value.

None of this argues the company is doomed — the point is the opposite. The balance sheet fix is genuine, which is why survival risk has come down materially. But a repaired balance sheet at a price that no longer reflects it, in a market where the quoted price is a liquidity artifact, is no longer a value trade. It is a float trade. For a disciplined buyer, the margin of safety here moved from the balance sheet into the hands of whoever holds the last few hundred shares — and that is not a comfortable place to be.